Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
37,155,456
-
Share change
-
-1,002,624
-
Total reported value
-
$75,053,420
-
Price per share
-
$2.02
-
Number of holders
-
64
-
Value change
-
-$2,280,903
-
Number of buys
-
29
-
Number of sells
-
18
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2025
As of 31 Dec 2025,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,155,456 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Privium Fund Management B.V., Aberdeen Group plc, Affinity Asset Advisors, LLC, Sio Capital Management, LLC, DAFNA Capital Management LLC, Kynam Capital Management, LP, Ikarian Capital, LLC, MORGAN STANLEY, and PLATINUM INVESTMENT MANAGEMENT LTD.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.